NovaBridge Biosciences (NBP): Weighted Average Diluted Shares

Annual figures by period end, from SEC filings.

220.26M
Year ended 2025-12-31
+5.1%
3-year compound annual growth
+7.0%
5-year compound annual growth
2017-12-31: 5.74M2018-12-31: 6.53M2019-12-31: 7.38M2020-12-31: 157.23M2021-12-31: 174.71M2022-12-31: 189.79M2023-12-31: 191.42M2024-12-31: 186.73M2025-12-31: 220.26M220.26M
2017-12-31 Weighted Average Diluted Shares (shares) 2025-12-31
Period endedWeighted Average Diluted SharesChange YoYSource filing
2025-12-31220.26M+18.0%2026-04-07, From 2025-01-01
2024-12-31186.73M-2.5%2026-04-07, From 2024-01-01
2023-12-31191.42M+0.9%2026-04-07, From 2023-01-01
2022-12-31189.79M+8.6%2025-04-03, From 2022-01-01
2021-12-31174.71M+11.1%2024-04-30, From 2021-01-01
2020-12-31157.23Mn/m2023-05-01, From 2020-01-01
2019-12-317.38M+13.1%2022-04-29, From 2019-01-01
2018-12-316.53M+13.7%2021-04-28, From 2018-01-01
2017-12-315.74Mn/a2020-04-29, From 2017-01-01